Skip to Main content Skip to Navigation
Journal articles

CYP3A5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipients.

Abstract : BACKGROUND: CYP3A5 genotyping might be useful to guide tacrolimus and sirolimus dosing. The aim of this study was to assess the influence of CYP3A5 polymorphism on everolimus metabolism and pharmacokinetics. METHODS: We investigated the effect of CYP3A5 6986A>G polymorphism (CYP3A5*1/*3 alleles) on the pharmacokinetics of everolimus in 28 renal transplant patients and on its in vitro hepatic metabolism using a bank of genotyped human liver microsomes (n=49). We further evaluated in vitro the contribution of CYP3A4, CYP3A5, and CYP2C8 to everolimus hepatic metabolism using recombinant enzymes. RESULTS: We found no association between CYP3A5 polymorphism and everolimus pharmacokinetics in renal transplant patients. On the other hand, no effect of CYP3A5 polymorphism was observed on the intrinsic clearance of everolimus by human liver microsomes, whereas that of tacrolimus (positive control) was 1.5-fold higher in microsomes carrying the CYP3A5*1 allele than in noncarriers. In vitro data showed that CYP3A4 is a better catalyst of everolimus metabolism than CYP3A5, whereas the opposite was observed for tacrolimus. CONCLUSIONS: This study provides direct and indirect evidence that CYP3A5 genotyping cannot help improve everolimus therapy.
Document type :
Journal articles
Complete list of metadatas

Cited literature [17 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00542366
Contributor : Pierre Marquet <>
Submitted on : Friday, March 30, 2012 - 4:10:19 PM
Last modification on : Monday, September 10, 2018 - 3:38:56 PM
Long-term archiving on: : Tuesday, December 13, 2016 - 6:15:14 PM

Files

inserm-00542366_edited.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Nicolas Picard, Koukeb Rouguieg-Malki, Nassim Kamar, Lionel Rostaing, Pierre Marquet. CYP3A5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipients.. Transplantation, Lippincott, Williams & Wilkins, 2011, 91 (6), pp.652-6. ⟨10.1097/TP.0b013e31820ae4ac⟩. ⟨inserm-00542366⟩

Share

Metrics

Record views

274

Files downloads

1152